Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Bevacizumab in Patients With Recurrent or Progressive Meningiomas

NCT01125046 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT01125046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01125046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Bevacizumab in Patients With Recurrent or Progressive Meningiomas
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Completed
Start date
June 17, 2010
Completion date
December 31, 2018
Enrollment
50 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acoustic schwannoma, adult anaplastic meningioma, adult ependymoma, adult grade i meningioma, adult grade ii meningioma, adult meningeal hemangiopericytoma, adult papillary meningioma, neurofibromatosis type 1, neurofibromatosis type 2, recurrent adult brain tumor